Balneg, Callie Joyce D.
HRN: 26-14-91 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/15/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
03/15/2025
03/22/2025
IV
230 Mg
Q6
PCAP C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes